Evidence map›Paper›PMID 32500432›Full record

ArticleInternational journal of colorectal disease2020

The impact of COVID-19 pandemic in the colorectal cancer prevention.

Giovanna Del Vecchio Blanco, Emma Calabrese, Livia Biancone, Giovanni Monteleone, Omero Alessandro Paoluzi

Open access · bronzeAbstract read
In one paragraph

Article in International journal of colorectal disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. IMPACT OF THE COVID-19 PANDEMIC ON THE EMERGENCY SURGICAL TREATMENT OF COLORECTAL CANCER.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Giovanna Del Vecchio BlancoGastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. giovanna.del.vecchio.blanco@uniroma2.it.
Emma CalabreseGastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Livia BianconeGastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Giovanni MonteleoneGastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Omero Alessandro PaoluziGastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.ORCID http://orcid.org/0000-0002-5393-5796
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) has led to a policy of severe restrictions in almost all countries strongly involved by the pandemic. National Health System is among activities suffering from the COVID-19 and the lockdown.

aimTo evaluate the impact of COVID-19 in colorectal cancer (CRC) prevention.

methodsWe report the change in the hospital organization to meet the growing healthcare needs determined by COVID-19. The limitations of CRC prevention secondary to COVID-19 and their effects on the healthcare are analyzed considering the features of the CRC screening programs in the average-risk population and endoscopic surveillance in patients with inflammatory bowel diseases (IBD).

resultsThe interruption of CRC prevention may lead to a delayed diagnosis of CRC, possibly in a more advanced stage. The economic burden and the impact on workload for gastroenterologists, surgeons, and oncologists will be greater as long as the CRC prevention remains suspended. To respond to the increased demand for colonoscopy once COVID-19 will be under control, we should optimize the resources. It will be necessary to stratify the CRC risk and reach an order of priority. It should be implemented the number of health workers, equipment, and spaces dedicated to performing colonoscopy for screening purpose and in subjects with alarm symptoms in the shortest time. To this aim, the funds earmarked for healthcare should be increased.

conclusionThe economic impact will be dramatic, but COVID-19 is the demonstration that healthcare has to be the primary goal of humans.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralColorectal NeoplasmsCOVID-19Early Detection of CancerHealth Care RationingHealth Services AccessibilityHumansItalyNational Health ProgramsSARS-CoV-2ColonoscopyColorectal cancerColorectal cancer screeningCOVID-19Fecal occult blood test

Identifiers

PMID32500432
PMCPMC7271141
OpenAlexW3033521222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.